In Re: Fosamax Products Liability Litigation

Track this case

Case overview

Case Number:

1:06-md-01789

Court:

New York Southern

Nature of Suit:

365 Personal Inj. Prod. Liability

Multi Party Litigation:

Multi-district Litigation

Judge:

John F. Keenan

Firms

Companies

Sectors & Industries:

February 05, 2013
Merck Loses Final Bellwether Trial In Fosamax MDL

Merck & Co. Inc. suffered a blow during the last bellwether trial in multidistrict litigation alleging bone drug Fosamax causes jaw deterioration, as a New York federal jury ruled Tuesday that the pharmaceutical giant failed to properly warn of the treatment's risks.
November 21, 2012
Judge Won't Subject All Fosamax MDL Claims To Lone Pine

The New York federal judge overseeing multidistrict litigation that includes more than 950 suits alleging Merck &. Co. Inc.'s osteoporosis drug Fosamax causes jaw deterioration granted a so-called Lone Pine order on Tuesday requiring some plaintiffs to support their claims with expert reports.
March 02, 2012
Merck Action Didn't Stop The Clock, Va. High Court Says

The Virginia Supreme Court ruled Friday that a proposed class action over Merck & Co. Inc.'s Fosamax did not postpone the statute of limitations for unnamed class members who launched individual suits claiming the osteoporosis drug causes jaw deterioration.
November 28, 2011
Fordham Professor To Lead Fosamax Settlement Talks

A New York federal judge last week chose a Fordham University School of Law professor as a special master tasked with brokering a settlement of roughly 900 suits consolidated in a multidistrict litigation alleging Merck & Co. Inc.'s Fosamax causes jaw deterioration.
October 03, 2011
Jury Lets Merck Off Hook In Fosamax Bellwether Suit

A New York federal jury on Monday sided with Merck & Co. Inc. in a bellwether case in multidistrict litigation alleging Fosamax causes jaw deterioration — the fourth jury to do so in litigation over the osteoporosis drug.
August 30, 2011
Merck Gets Bellwether Suit Slashed In Fosamax MDL

A New York federal judge on Tuesday dismissed every claim but one in a bellwether case in multidistrict litigation alleging Merck & Co. Inc.'s osteoperosis drug Fosamax causes jaw deterioration, allowing only a design defect claim to stand for trial.
February 08, 2011
Judge Orders 2 More Bellwethers In Fosamax MDL

Merck & Co. will help select two additional bellwether cases for trial in a multidistrict litigation over its osteoporosis drug Fosamax following a federal judge's ruling that a couple of key issues still needed to be hashed out in court.
October 10, 2007
Merck, Patients Fight Over Fosamax Discovery Tab

Merck and the patients who sued over its bone drug Fosamax are sparring over who should fund discovery requests in the multidistrict litigation.

← Previous
1
2
Next →